Immunologic strategies for the treatment of non-small cell lung cancer

Affiliations

Review

Tokujiro Yano et al. Surgery. 2002 Jan.

. 2002 Jan;131(1 Suppl):S232-5.

doi: 10.1067/msy.2002.119794.

No abstract available

Similar articles

Clinical Approaches to Immunotherapy in Non-Small Cell Lung Cancer: Current and Future Perspectives.
Rice SJ, Miller B, Wagman M, Jamorabo DS, Liu X, Belani CP. Rice SJ, et al. Curr Mol Pharmacol. 2016;9(3):183-195. doi: 10.2174/1874467208666150716120108. Curr Mol Pharmacol. 2016. PMID: 26177648 Review.
Vaccines and immunotherapy for non-small cell lung cancer.
Morgensztern D, Goodgame B, Govindan R. Morgensztern D, et al. J Thorac Oncol. 2010 Dec;5(12 Suppl 6):S463-5. doi: 10.1097/01.JTO.0000391367.63882.79. J Thorac Oncol. 2010. PMID: 21102240 No abstract available.
Immunogenic targets in non-small cell lung cancer: more is more.
Gnjatic S. Gnjatic S. Clin Cancer Res. 2005 Aug 1;11(15):5331-2. doi: 10.1158/1078-0432.CCR-05-0880. Clin Cancer Res. 2005. PMID: 16061843 No abstract available.
Selecting patients for immune checkpoint inhibition in lung cancer.
Garon EB. Garon EB. Clin Adv Hematol Oncol. 2015 Aug;13(8):490-2. Clin Adv Hematol Oncol. 2015. PMID: 26351808 No abstract available.
New strategies in lung cancer: translating immunotherapy into clinical practice.
Forde PM, Kelly RJ, Brahmer JR. Forde PM, et al. Clin Cancer Res. 2014 Mar 1;20(5):1067-73. doi: 10.1158/1078-0432.CCR-13-0731. Epub 2014 Jan 27. Clin Cancer Res. 2014. PMID: 24470514 Review.